Clinical Trials Directory

Trials / Completed

CompletedNCT01455623

Development and Validation of a Disability Severity Index for CMT

Development and Validation of a Disability Severity Index for Charcot Marie Tooth Disease

Status
Completed
Phase
Study type
Observational
Enrollment
291 (actual)
Sponsor
University of Iowa · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Accepted

Summary

It is necessary for outcome measures to accurately reflect the state of health of a person in order for clinical trials to show benefit. The most commonly used outcome measure for Charcot Marie Tooth Disease (CMT) is the CMT Neuropathy Score, which uses cutoffs of points designated as mild (0-10 points), moderate (11-20) or severe (21-36). These terms are arbitrary. This study is looking to base mild, moderate, and severe on what both people affected with CMT and those who provide for people with CMT consider appropriate.

Conditions

Timeline

Start date
2011-06-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2011-10-20
Last updated
2014-03-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01455623. Inclusion in this directory is not an endorsement.

Development and Validation of a Disability Severity Index for CMT (NCT01455623) · Clinical Trials Directory